BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38596674)

  • 1. Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study.
    Qu W; Chen C; Cai C; Gong M; Luo Q; Song Y; Yang M; Shi M
    Front Immunol; 2024; 15():1327779. PubMed ID: 38596674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study.
    She Y; He B; Wang F; Zhong Y; Wang T; Liu Z; Yang M; Yu B; Deng J; Sun X; Wu C; Hou L; Zhu Y; Yang Y; Hu H; Dong D; Chen C; Tian J
    EBioMedicine; 2022 Dec; 86():104364. PubMed ID: 36395737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Yang M; Li X; Cai C; Liu C; Ma M; Qu W; Zhong S; Zheng E; Zhu H; Jin F; Shi H
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38127071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
    Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
    Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of [
    Zhang L; E H; Huang J; Wu J; Li Q; Hou L; Li C; Dai C; Deng J; Yang M; Ma M; Ren Y; Luo Q; Zhao D; Chen C
    Eur Radiol; 2023 Dec; 33(12):8564-8572. PubMed ID: 37464112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of
    Zhuang F; Haoran E; Huang J; Wu J; Xu L; Zhang L; Li Q; Li C; Zhao Y; Yang M; Ma M; She Y; Chen H; Luo Q; Zhao D; Chen C
    Lung Cancer; 2023 Apr; 178():20-27. PubMed ID: 36764154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features.
    Yang N; Yue HL; Zhang BH; Chen J; Chu Q; Wang JX; Yu XP; Jian L; Bin YW; Liu SY; Liu J; Zeng L; Yang HY; Zhou CH; Jiang WJ; Liu L; Zhang YC; Xiong Y; Wang Z
    Thorac Cancer; 2023 Oct; 14(28):2869-2876. PubMed ID: 37596822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non-small-cell lung cancer.
    Han R; Zhang Y; Wang T; Xiao H; Luo Z; Shen C; Li J; Zhao C; Li L; Zhu M; Du H; Tang H; Ma Z; Wang Y; He Y
    Cancer Sci; 2023 Jun; 114(6):2569-2583. PubMed ID: 36880750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
    Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
    Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
    Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
    Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
    BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided diagnosis of distal metastasis in non-small cell lung cancer by low-dose CT based radiomics and deep learning signatures.
    Song X; Duan X; He X; Wang Y; Li K; Deng B; Chen X; Wang Y; Li M; Shan H
    Radiol Med; 2024 Feb; 129(2):239-251. PubMed ID: 38214839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.
    Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ct-based subregional radiomics using hand-crafted and deep learning features for prediction of therapeutic response to anti-PD1 therapy in NSCLC.
    Hu Y; Jiang T; Wang H; Song J; Yang Z; Wang Y; Su J; Jin M; Chang S; Deng K; Jiang W
    Phys Med; 2024 Jan; 117():103200. PubMed ID: 38160516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer.
    Bao X; Bian D; Yang X; Wang Z; Shang M; Jiang G; Shi J
    Eur Radiol; 2023 Dec; 33(12):9182-9193. PubMed ID: 37382618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined model using pre-treatment CT radiomics and clinicopathological features of non-small cell lung cancer to predict major pathological responses after neoadjuvant chemoimmunotherapy.
    Wang F; Yang H; Chen W; Ruan L; Jiang T; Cheng L; Jiang H; Fang M
    Curr Probl Cancer; 2024 May; 50():101098. PubMed ID: 38704949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with 
Chemotherapy in Resectable Non-small Cell Lung Cancer].
    Zhou S; Hao X; Yu D; Liu S; Cao X; Su C; Song X; Xiao N; Li Y; Yang W; Zhao D; Wang J; Liu Z; Xu S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):420-425. PubMed ID: 34024062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
    Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical perspective in neoadjuvant chemoimmunotherapy for stage II-III non-small cell lung cancer.
    Hong T; Sun T; Zhang M; Liu X; Yuan Y; Dolo PR; Chen B; Zhang H
    Thorac Cancer; 2021 Oct; 12(20):2796-2802. PubMed ID: 34463034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.